Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial MarketWatch - ... Inc. (CA:TLN: news, chart, profile) is a biotechnology company developing pharmaceutical products in the areas of oncology and infectious disease. ... |
« ECM Market Leader Open Text Kicks Off Content World Conference ... - MarketWatch | Main | SRI Awarded National Institute on Drug Abuse Contract for Chemical ... - MarketWatch »
November 30, 2008
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f120883301053625a9e0970b
Listed below are links to weblogs that reference Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial - MarketWatch:
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Last articles
- Les nouveaux moteurs de la semaine : Rue des Professionnels, ReportLinker, Volti, Annuaire Entreprises, Jetcost et Wasalive (Abondance actu - vendredi 9 mars 2007)
- Reportlinker.com : un moteur de recherche d'études de marché.... - Le JP Blog - technoselect
- Reportlinker, lauréat de Tremplin Entreprises, 8 et 9 juilllet 2008, au Sénat, le premier événement du capital investissement en France
- Un moteur de recherche dédié aux études de marchés: Reportlinker
- Reportlinker, le moteur de recherche d'études de marché
- Sparus, Reportlinker et Quescom espoirs 2007 de l'IE-Club
- Reportlinker: L'IE-Club récompense les PME françaises innovantes
- Le prix IE-Club distingue les PME Kxen, Sparus Software et Reportlinker
- Présentation vidéo de Reportlinker
- Jeudi 2.0 : Recherche verticale ou méta recherche - Reportlinker
Comments